Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling.

Xiao, Jin-Fen; Caliri, Andrew W; Duex, Jason E; Theodorescu, Dan

Xiao, Jin-Fen; Caliri, Andrew W; Duex, Jason E; Theodorescu, Dan.

Afiliação

Xiao JF; Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Caliri AW; Department of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Duex JE; Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA 90048, USA.
Theodorescu D; Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Cancers (Basel) ; 13(19)2021 Sep 29.

Article em En | MEDLINE | ID: mdl-34638374

Palavras-chave

DNA; bladder cancer; erdafitinib; fibroblast growth factor receptor; kinase inhibitors; mutation; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google